Rate of Onset of Inhibition of Gut-Wall and Hepatic CYP3A by Clarithromycin

European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-012-1339-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)

Anesthesiology
AnesthesiologyPain Medicine
2012English

CYP3A Probes Can Quantitatively Predict the in Vivo Kinetics of Other CYP3A Substrates and Can Accurately Assess CYP3A Induction and Inhibition

Molecular Interventions
2005English

CYP3A Gene Expression in Human Gut Epithelium

Pharmacogenetics
1994English

Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2016English

Silent Perforation of the Gut Wall

BMJ
1946English

Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition in Vivo in Rats

Cannabis and Cannabinoid Research
Alternative MedicinePharmacologyComplementary
2020English

Inhibition of Human Hepatic Cytochrome P450s and Steroidogenic CYP17 by Nonylphenol

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2002English

Studies on the Inhibition of Hepatic Lipogenesis by Carboxylic Acids

Biochemical Society Transactions
Biochemistry
1980English

Inhibition by Acetyl-CoA of Hepatic Carnitine Acyltransferase and Fatty Acid Oxidation

Biochemical Journal
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy